New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 17, 2011
09:11 EDTAGNAllergan's Botox migraine should be well received, says Susquehanna
Susquehanna is raising its forecast for Allergan's Botox sales following an investor lunch with an expert neurologist. The firm cited better than expected efficacy, the target market, and potential for a high level of acceptance and retention rates. Shares are Positive rated with a $93 price target.
News For AGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for AGN

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use